Century Therapeutics, Inc. — Director's Dealing 2021

Jun 17, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2021-06-17

Reporting Person: Carr Douglas (VP Finance & Operations)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	203430	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$7.27	2031-04-15	Common Stock (15897)		Direct

Footnotes

F1: The option vests 25% on the first anniversary of the closing of the Issuer's initial public offering, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.